Deficiency of 5‐HT<sub>2B</sub> receptors alleviates atherosclerosis by regulating macrophage phenotype through inhibiting interferon signalling
This article is part of a themed issue Drugs and Drug Targets in Metabolic and Chronic Inflammatory Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.20/issuetoc.
Authors
- Xuya Kang (ORCID: https://orcid.org/0000-0002-6593-5347)
- Erdan Dong (ORCID: https://orcid.org/0009-0006-8737-5308)
- Jintao Han (ORCID: https://orcid.org/0000-0002-0731-7006)
- Nanping Wang (ORCID: https://orcid.org/0000-0002-8528-8132)
- Yaohua Xu
- Zhipeng Wang
- Yan Zhang (ORCID: https://orcid.org/0000-0002-8322-467X)
- Li Fang (ORCID: https://orcid.org/0000-0002-1076-7729)
- Beilei Zhao
- Yahan Liu (ORCID: https://orcid.org/0000-0002-5948-4615)
- Yanqing Zhao (ORCID: https://orcid.org/0009-0009-5388-0025)
Institutions
- Qingdao University (CN)
- Dalian Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Research Management (Norway) (NO)
- Affiliated Hospital of Qingdao University (CN)
- Qingdao Municipal Hospital (CN)
- First Affiliated Hospital of Dalian Medical University (CN)
- Peking University Third Hospital (CN)
- Anhui Normal University (CN)
- East China Normal University (CN)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2024-09-04
- DOI
- https://doi.org/10.1111/bph.17315
- Citations
- 2
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.48
Funders
- National Natural Science Foundation of China
- Beijing Municipal Natural Science Foundation